A recent multinational, federated analysis of LEGEND-T2DM study published that Sodium-glucose cotransporter 2 inhibitors ...

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and ...

One of the biopharma industry’s marvels of the 2020s has been the enormous medical and financial success of the GLP-1 class ...

A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...

Terns Pharmaceuticals Inc. (NASDAQ:TERN) revealed topline data from its Phase 1 single and multiple-ascending dose (SAD and ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...

“These data validate the potential of TERN-601 for the treatment of obesity as monotherapy or in combination with agents such as TERN ... to demonstrate potent GLP-1R agonism with TERN-601 ...

Wadden called for additional studies delving into the safety of GLP-1 agonists and similar weight-management agents among patients with more significant mental health disorders than were included ...

Proof of Concept Study in Rapid Acting GLP-1 to commence in October 2024 with data expected in November 2024-Pre-clinical study to explore use of MODD1 pump as a personalized delivery system for ...